ENPP3 p.Arg405His
c.1214G>A · VCV3844973
Computational evidence
| Protein change | ||
| AlphaMissense | 0.524 | ambiguous |
|---|---|---|
| REVEL | 0.743 | pathogenic-leaning |
| SaProt | LLR -10.01 | damaging |
| ⇒ REVEL and SaProt both call this damaging; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 8.7 | GERP 0.76, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 110 kb · p 0.42 · regional, not allelic |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.142% | 705 |
| Remaining individualsnot grpmax-eligible | 0.0192% | 5,205 |
| South Asiangrpmax | 0.0165% | 6,071 |
| African / African-American | 0.00535% | 18,709 |
| European (non-Finnish) | 0.0039% | 25,649 |
| Finnishnot grpmax-eligible | 0.00313% | 31,986 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ENPP3
- Protein
- p.Arg405His
- Coding
- c.1214G>A
- MANE Select
- NM_005021
- Type
- single nucleotide variant
- Location
- chr6:131685457 (GRCh38)
- Gene constraint
- LOEUF 1.211 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 95.50 · 3 PDB
- Residue 405
- a β-strand; a disulfide bond; the 'phosphodiesterase' region
Similar variants
- ENPP3 p.Arg405Cys Uncertain significance ★ ⚠ same residue
- ENPP3 c.762+4T>C Likely benign ★★ same type
- CTAGE9 p.Ala668Thr Uncertain significance ★ ⚠ same type
- CTAGE9 p.Asp478Tyr Uncertain significance ★ ⚠ same type
- CTAGE9 p.Glu332Lys Uncertain significance ★ ⚠ same type
- CTAGE9 p.Glu414Asp Uncertain significance ★ ⚠ same type
- CTAGE9 p.Ile207Thr Uncertain significance ★ ⚠ same type
- ENPP3 p.Ala248Asp Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/enpp3-p-arg405his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown